We were unable to find significant differences in the relative RUNX1 expression in the liver between patients with or without NAFLD, probably because the peak RUNX1 expression is found in patients with SS, and not in patients with NL or NASH. Here, RUNX1 is linked to metabolic dysfunction-associated steatotic liver disease.